Cystic Fibrosis is caused by a delta F508 mutation in the ion channel CFTR gene, causing thick mucuous; inherited in an autosomal recessive inheritance pattern
Presentation: poor growth, recurrent respiratory infections, finger clubbing
Diagnosis: sweat test- raised Na+ levels
Complications: diabetes, pseudomonas colonisation
Autosomal recessive inheritance; CFTR gene, delta F508 mutation
Baseline rate of carrier is 1/25, 4%.
Ultimately fatal disease, life expectancy currently 30-40yrs
History
Poor growth,
Recurrent respiratory infections,
Examination
Finger clubbing
Nasal polyps
Investigations
Screened as part of the Newborn Screening
Sweat test: high Na+ diagnostic
Pulmonary function tests
Deranged LFTs
Diagnosis: raised Chloride in sweat or genetic testing
No disease modifying therapies in the UK
Antibiotic nebulisers
Pancreatic supplements
Mucolytics and chest physio
NIV, lung transplants
Curing Cystic Fibrosis
Currently gene therapy is being developed in the USA: a once off injection, that is very expensive.
Preventing Cystic Fibrosis
Due to it being an autosomal recessive condition, prenatal screening to chose embryos with only heterozygous traits in those with the disease has the ability to greatly reduce the incidence of the cystic fibrosis trait and disease.
Complications
Pseudomonas lung colonisation
Staph aureus lung colonisation
Diabetes mellitus (type 3), from
Infertility (in males, failure of vas deferens)
Bronchial artery aneurysm: PC haemoptysis, Investigation: CTPA, Mx tranexamic acid
Lung transplant
Indications: home oxygen
Contraindications
BMI < 15
Active mycobaceterial infection (not pseudomonas colonisation)
Persistent non compliance- 5+
Infertility
98% CF Men are infertile
25% CF Females are infertile
15% population baseline infertility rate
Produced 2024